Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vivek Narasimhan"'
Publikováno v:
The Journal of OncoPathology. 2:59-63
Publikováno v:
Paediatric drugs. 16(1)
Giant cell tumor of bone (GCTB) is a rare primary bone tumor that primarily affects young adults, but can be seen in children. The primary modality of treatment is surgical resection; however, this is not always possible given the location and extent
Autor:
Susan V. Bukata, Vivek Narasimhan, Neal Shiv Chawla, Lawrence R. Menendez, Sant P. Chawla, Victoria S. Chua, Kamalesh Kumar Sankhala, Earl Brien, William E. Mendanha, Nicholas M. Bernthal
Publikováno v:
Journal of Clinical Oncology. 33:10528-10528
10528 Background: GCTB are aggressive osteolytic tumors, which are characterized by local bone destruction and soft tissue invasion. There have been limited non-surgical treatments, including radiation therapy. However, an unacceptable rate of post r
Autor:
Kamalesh Kumar Sankhala, Monish Sodhi, Sant P. Chawla, Doris Quon, Nina Krishna, Daniel J. Levitt, Victoria S. Chua, Scott Wieland, Hillary Dinh, Vivek Narasimhan, Allison Bonk
Publikováno v:
Journal of Clinical Oncology. 31:2550-2550
2550 Background: Aldoxorubicin is a novel drug that covalently binds to albumin in the circulation with release in low pH environments. Preclinical studies in pancreatic and ovarian tumor xenograft models demonstrated that aldoxorubicin plus doxorubi